104447-74-7 = 5318-27-4 + 873055-33-5 反应条件:1.1 Reagents: Hydrazine Hydrate (1:1) Catalysts: Palladium (On Carbon) Solvents: Methanol; 5 Min,80 °C 标题:Selective Reduction Of Halogenated Nitroarenes With Hydrazine Hydrate In The Presence Of Pd/c 作者:Li,Fang; Frett,Brendan; Li,Hong-Yu 参考文献:Synlett 日期:2014 卷标:25(10) 页码:1403-1408
2,4-二硝基甲苯置于氮体系中,用 Ethanol-N,N-Dimethylformamide,苯 作为反应溶剂,化学反应生成 6-氨基吲哚 参考文献:Intermediates For Indoles 标题:Intermediates For Indoles 摘要:邻硝基甲苯与甲酰胺缩醛反应,反应生成相应的邻硝基-β-氨基苯乙烯,经还原后发生环化反应反应生成吲哚.
专利信息
专利号:WO-2004083202-A1 优先权日:2003-03-19 标 题:A process for the preparation of indolymaleimides 发明人:RAMAKRISHNA VENKATA SATYA NIRO; KAMBHAMPATI RAMA SASTRI; SHIRSATH VIKAS SHREEKRISHNA; JASTI VENKATESHWARLU 权利人:SUVEN LIFE SCIENCES LTD; RAMAKRISHNA VENKATA SATYA NIRO; KAMBHAMPATI RAMA SASTRI; SHIRSATH VIKAS SHREEKRISHNA; JASTI VENKATESHWARLU 摘要:The present invention relates to an improved method of synthesis for indolylmaleimides, such as symmetrical and non-symmetrical bis-indolylmaleimides as well as indolylmaleimides. The process of the present invention has advantages such as shorter reaction time along with fewer amounts of impurity. The yield and purity of the product are good and thus the process has wider industrial applicability.
专利号:WO-2008028776-A1 优先权日:2006-09-06 标题 :Agents containing bioquinones and specific emulsifiers 发明人:SCHULZE ZUR WIESCHE ERIK; SCHEUNEMANN VOLKER; POPPE ELISABETH; WELSS THOMAS; GIESEN MELANIE 权利人:HENKEL KGAA; SCHULZE ZUR WIESCHE ERIK; SCHEUNEMANN VOLKER; POPPE ELISABETH; WELSS THOMAS; GIESEN MELANIE 摘要:The invention relates to cosmetic agents, in particular hair treatment agents, containing at least one specific emulsifier and at least one bioquinone. Treating the hair with said agents activates the keratin synthesis of hair keratin that declines with age.
专利号:US-9334275-B2 优先权日:2011-12-19 标题:Processes for preparing indoles 发明人:YOSHIKAI NAOHIKO; WEI YE 权利人:UNIV NANYANG TECH 摘要:Methods for the synthesis of an indole in provided. Methods comprise oxidizing a N-aryl imine in the presence of a palladium-based catalyst, an oxidant, and a solvent.
专利号:EP-3305900-A1 优先权日:2005-12-01 标 题 :Enzymatic encoding methods for efficient synthesis of large libraries
专利号:US-2023024032-A1 优先权日:2019-12-19 标题 :Method for synthesizing celosianin ii, method for synthesizing betaxanthin, amyloid-beta polymerization inhibitor or therapeutic or prophylactic agent for alzheimer's disease, amyloid peptide aggregation inhibitor, and hiv-1 protease activity inhibitor 发明人:MORI MASASHI; IMAMURA TOMOHIRO; TAKIZAKI Izumi; MIZUNO AKIKO; HIGASHIMURA Yasuki; KOGA HIRONORI; MIZUKOSHI HIROHARU 权利人:MORI MASASHI 摘要:The present invention provides a method of synthesizing celosianin II, a method of synthesizing a betaxanthin, an amyloid-β polymerization inhibitor or a therapeutic or preventive agent for Alzheimer's, an amyloid peptide aggregation inhibitor, and an HIV-1 protease activity inhibitor. A gene having a celosianin II synthesis ability has been isolated from quinoa, and a method of synthesizing celosianin II of the present invention has been constructed. Besides, it has been recognized that celosianin II or the like serves as an active ingredient of each of an amyloid-β polymerization inhibitor or a therapeutic or preventive agent for Alzheimer's, an amyloid peptide aggregation inhibitor, and an HIV-1 protease activity inhibitor.
专利号:US-2012009151-A1 优先权日:2007-12-21 标题 :Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof 发明人:HAN AMY QI; COBURN GLEN A; PROVONCHA KATHLEEN P; ROTSHTEYN YAKOV 权利人:HAN AMY QI; COBURN GLEN A; PROVONCHA KATHLEEN P; ROTSHTEYN YAKOV; PROGENICS PHARM INC 摘要:Disclosed herein are novel triazines and related compounds, the synthesis thereof, and compositions, including pharmaceutical compositions, comprising the novel triazines and related compounds. Such novel triazines and related compounds function to inhibit or block entry of viruses of the Flaviviridae family, including Hepatitis C virus (HCV), into cells that are susceptible to virus infection. These compounds are useful for the treatment, therapy and/or prophylaxis of viral diseases and infection, including HCV infection.